Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 78 Records) |
Query Trace: Melanoma and TP53[original query] |
---|
Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 2020 9 70 (3): 667-677. Yang Huayu, Sun Lejia, Guan Ai, Yin Huanhuan, Liu Meixi, Mao Xinxin, Xu Haifeng, Zhao Haitao, Lu Xin, Sang Xinting, Zhong Shouxian, Chen Qian, Mao Yil |
Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases. Oncotarget 2020 Aug 11 (33): 3118-3128. In Gino K, Poorman Kelsey, Saul Michelle, O'Day Steven, Farma Jeffrey M, Olszanski Anthony J, Gordon Michael S, Thomas Jacob S, Eisenberg Burton, Flaherty Lawrence, Weise Amy, Daveluy Steven, Gibney Geoffrey, Atkins Michael B, Vanderwalde A |
Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients. Cancers 2020 8 12 (9): . Hilke Franz J, Sinnberg Tobias, Gschwind Axel, Niessner Heike, Demidov German, Amaral Teresa, Ossowski Stephan, Bonzheim Irina, Röcken Martin, Riess Olaf, Garbe Claus, Schroeder Christopher, Forschner Andr |
Mutation profile of primary subungual melanomas in Caucasians. Oncotarget 2020 Jun 11 (25): 2404-2413. Borkowska Aneta, Szumera-Cieckiewicz Anna, Spalek Mateusz, Teterycz Pawel, Czarnecka Anna, Kowalik Artur, Rutkowski Pio |
Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies. Cancer reports (Hoboken, N.J.) 2020 Jul e1267. Naderi A |
Melanoma Genomics. Acta dermato-venereologica 2020 4 100 (11): adv00138. Newton-Bishop Julia, Bishop D Timothy, Harland Ma |
Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma. Neoplasma 2020 4 67 (5): 958-971. Goh A Y, Ramlogan-Steel C A, Jenkins K Sean, Steel J C, Layton C |
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations. PloS one 2020 15 (3): e0230306. DeLeon Thomas T, Almquist Daniel R, Kipp Benjamin R, Langlais Blake T, Mangold Aaron, Winters Jennifer L, Kosiorek Heidi E, Joseph Richard W, Dronca Roxana S, Block Matthew S, McWilliams Robert R, Kottschade Lisa A, Rumilla Kandelaria M, Voss Jesse S, Seetharam Mahesh, Sekulic Aleksandar, Markovic Svetomir N, Bryce Alan |
Differences in Genomic Alterations Between Brain Metastases and Primary Tumors. Neurosurgery 2020 Dec . Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar |
Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade. JCO precision oncology 2020 10 4 . Miller Peter G, Gibson Christopher J, Mehta Arnav, Sperling Adam S, Frederick Dennie T, Manos Michael P, Miao Benchun, Hacohen Nir, Hodi F Stephen, Boland Genevieve M, Ebert Benjamin |
NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay. Genes 2021 Jul 12 (7): . Olbryt Magdalena, Rajczykowski Marcin, Bal Wies?aw, Fiszer-Kierzkowska Anna, Cortez Alexander Jorge, Mazur Magdalena, Suwi?ski Rafa?, Wid?ak Wies?a |
Genetic alterations associated with multiple primary malignancies. Cancer medicine 2021 May . Nyqvist Jenny, Kovács Anikó, Einbeigi Zakaria, Karlsson Per, Forssell-Aronsson Eva, Helou Khalil, Parris Toshima |
Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients. Journal of dermatological science 2021 Apr . Kaneko Akira, Kanemaru Hisashi, Kajihara Ikko, Mijiddorj Tselmeg, Miyauchi Hitomi, Kuriyama Haruka, Kimura Toshihiro, Sawamura Soichiro, Makino Katsunari, Miyashita Azusa, Aoi Jun, Makino Takamitsu, Masuguchi Shinichi, Fukushima Satoshi, Ihn Hirono |
Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy. iScience 2021 3 24 (3): 102248. Chatrath Ajay, Ratan Aakrosh, Dutta Anind |
Tumor-Infiltrating Immune-Related Long Non-Coding RNAs Indicate Prognoses and Response to PD-1 Blockade in Head and Neck Squamous Cell Carcinoma. Frontiers in immunology 2021 11 12 692079. Ma Ben, Jiang Hongyi, Luo Yi, Liao Tian, Xu Weibo, Wang Xiao, Dong Chuanpeng, Ji Qinghai, Wang |
Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer. Computational and mathematical methods in medicine 2021 2021 1522250. Hu Sizhe, Zhao Xiaokang, Qian Feng, Jin Cancan, Hou Kaish |
Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatment. ESMO open 2021 1 6 (1): 100002. Byeon S, Cho H J, Jang K-T, Kwon M, Lee J, Lee J, Kim S |
Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma. Frontiers in immunology 2022 8 13 952413. Cai Jialiang, Wu Suiyi, Zhang Feng, Dai Z |
The Genetics of Early-Stage Melanoma in a Veteran Population. Frontiers in oncology 2022 6 12 887768. Cheung Kevin, Bossler Aaron D, Mott Sarah L, Zeisler Megan, McKillip Julie, Zakharia Yousef, Swick Brian L, Powers Jennifer |
Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation. The oncologist 2022 May . Huang Richard S P, Tse Julie Y, Harries Lukas, Graf Ryon P, Lin Douglas I, Murugesan Karthikeyan, Hiemenz Matthew C, Parimi Vamsi, Janovitz Tyler, Decker Brennan, Severson Eric, Levy Mia A, Ramkissoon Shakti H, Elvin Julia A, Ross Jeffrey S, Williams Erik |
Pan-cancer prognostic genetic mutations and clinicopathological factors associated with survival outcomes: a systematic review. NPJ precision oncology 2022 4 6 (1): 27. Kaubryte Jurgita, Lai Alvina |
Somatic Mutations in TP53 Gene in Colombian Patients With Non-melanoma Skin Cancer. Cancer diagnosis & prognosis 2022 4 2 (1): 107-114. Dary Gutiérrez-Castañeda Luz, Nova John, Irene Cerezo-Cortés Mar |
Vaginal melanoma in Denmark from 1980 to 2018: A population-based study based on genetic profile and survival. Gynecologic oncology 2022 Feb . Yazdanfard Natacha Würtz, Mikkelsen Lauge Hjorth, Behrendt Nille, Fuglsang Katrine, Blaakær Jan, Hölmich Lisbet Rosenkrantz, Frøding Ligita Paskeviciute, Munch-Petersen Helga Fibiger, Heegaard Steff |
Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & translational immunology 2023 8 12 (8): e1465. John Wen-Cheng Chang, Chien-Jung Huang, Wen-Kuan Huang, Yu-Chao Wang, Jia-Juan Hsieh, Yao-Yu Chang, Yen-Lin Huang, Chia-Ling Wu, Yeh-Han Wang, Shu-Jen Chen, Kien Thiam Tan, Chiao-Ping Chen, Chiao-En |
Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. Cancer cell international 2023 8 23 (1): 187. Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo, Fang Wa |
Genomic profiling of a metastatic anaplastic melanocytic neuroectodermal tumor arising from a mature thymic teratoma as part of a mediastinal germ cell tumor. Cold Spring Harbor molecular case studies 2023 5 9 (2): . Sylvain Mayeur, Benoit Lhermitte, Justine Gantzer, Anne Molitor, Tristan Stemmelen, Sébastien Meyer, Aline Kolmer, Jean-Emmanuel Kurtz, Seiamak Bahram, Raphael Carapi |
Germline genomic findings in children and young adults with melanocytic tumors. Pediatric blood & cancer 2023 4 e30361. Margaret B Nagel, Melissa R Perrino, Regina Nuccio, Alise K Blake, Lynn Harrison, Kim E Nichols, Alberto S Pap |
Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 2023 4 7 e2200421. Wisinski Kari B, Flamand Yael, Wilson Melissa A, Luke Jason J, Tawbi Hussein A, Hong Fangxin, Mitchell Edith P, Zwiebel James A, Chen Helen, Gray Robert J, Li Shuli, McShane Lisa M, Rubinstein Lawrence V, Patton David, Williams P Mickey, Hamilton Stanley R, Behrens Robert J, Pennington Kathryn P, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
Molecular Profiling and the Interaction of Somatic Mutations with Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) in a Population Exposed to Arsenic. Cells 2024 6 13 (12): . Farzana Jasmine, Maria Argos, Yuliia Khamkevych, Tariqul Islam, Muhammad Rakibuz-Zaman, Mohammad Shahriar, Christopher R Shea, Habibul Ahsan, Muhammad G Kibri |
- Page last reviewed:Feb 1, 2024
- Content source: